Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

Makary resigns, with Diamantas named as acting FDA commissioner

The resignation comes after reports suggested the President was considering firing him.

Latest news

BMS and Hengrui forge $15.2bn alliance for early-stage drugs

The two companies will trade the greater Chinese and US rights to certain programmes under their jurisdiction, while working in tandem to progress these assets.

Isomorphic Labs receives $2.1bn for AI drug development

The proceeds will be used to accelerate Isomorphic Labs’ pipeline of therapeutic programmes and further develop its IsoDDE AI drug design engine.

EU advances plans to reduce reliance on drug imports

Agreement on the proposed Critical Medicines Act (CMA) represents an important step for boosting the EU pharma sector.

UAE approves AstraZeneca’s Baxfendy for hypertension

The regulatory approval is supported by data from two Phase III studies, BaxHTN and Bax24.

FDA weighs drug repurposing pathway for underserved diseases

Approved drugs could be expanded into disease areas with limited commercial potential, providing supporting data is available.